≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

TMD muscular pain linked with fibromyalgia

EFO Endpoint Browser PheWeb

DENTAL_TMD_FIBRO

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • M13_FIBROMYALGIA
3761

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — K07.60
  • Cause of death: ICD-10 — K07.60
  • Operations: NOMESCO codes — ^SHA03|^SHA04|^SHB00

3 out of 7 registries used, show all original rules.

328

4. Check minimum number of events

None

328

5. Include endpoints

None

328

6. Filter based on genotype QC (FinnGen only)

328

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF11

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 328 315 13
Unadjusted period prevalence (%) 0.10 0.11 0.01
Median age at first event (years) 47.67 47.67 47.68

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
289
Matched controls
2887
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M79.7
ICD-10 Finland
Fibromyalgia
+∞
323.0
289
71
K07.60
ICD-10 Finland
Snapping jaw
80.3
182.5
208
89
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
31.2
134.6
208
219
M79.0
ICD-10 Finland
Rheumatism, unspecified
52.2
125.7
152
60
N06AX21
ATC
duloxetine; oral
17.7
94.3
173
224
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
20.9
90.6
147
136
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
32.6
86.2
116
58
N03AX16
ATC
pregabalin; oral
10.5
71.6
189
440
N03AX12
ATC
gabapentin; oral
11.6
70.5
159
276
M79.1
ICD-10 Finland
Myalgia
12.1
69.0
148
231
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
20.2
58.5
91
64
N06AA09
ATC
amitriptyline; systemic
10.9
54.0
116
167
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
11.5
53.4
110
146
SBB10
NOMESCO Finland
Teeth copy
14.1
48.6
88
87
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
6.6
48.6
192
667
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
6.6
47.8
211
837
SAA03
NOMESCO Finland
Extended examination of mouth
6.3
45.1
210
859
SAA04
NOMESCO Finland
Special inverstigation of mouth
15.7
44.1
75
63
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
20.5
43.4
66
41
F45.8
ICD-10 Finland
Other somatoform disorders
9.4
43.2
99
152
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
40.2
42.5
53
16
N06AX16
ATC
venlafaxine; oral
6.9
42.3
128
298
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
7.5
40.6
111
222
N02AX02
ATC
tramadol; systemic, rectal
5.5
40.0
197
809
H02AB06
ATC
prednisolone; systemic
5.5
38.3
217
1021
WZB00
NOMESCO Finland
Telephone receipt or other advice
5.2
37.6
168
606
M79.6
ICD-10 Finland
Pain in limb
5.1
37.4
185
744
G44.2
ICD-10 Finland
Tension-type headache
6.4
36.6
115
272
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
5.0
36.2
193
829
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
12.6
35.5
66
66
M25.5
ICD-10 Finland
Pain in joint
4.8
34.6
173
682
R52.2
ICD-10 Finland
Other chronic pain
17.6
34.5
55
38
G50.1
ICD-10 Finland
Atypical facial pain
24.3
34.5
49
24
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.6
31.3
156
591
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
21.7
31.3
46
25
A02BC05
ATC
esomeprazole; systemic
4.4
31.1
191
884
N06CA01
ATC
amitriptyline and psycholeptics; systemic
6.5
30.6
89
184
Z01.8
ICD-10 Finland
Other specified special examinations
4.8
30.4
128
408
G47.3
ICD-10 Finland
Sleep apnoea
5.1
30.0
114
325
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.5
29.1
100
253
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
4.2
28.6
202
1029
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.4
28.5
140
512
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
24.2
28.3
40
19
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
6.7
27.3
76
146
M54.4
ICD-10 Finland
Lumbago with sciatica
4.9
27.3
108
316
P01BA02
ATC
hydroxychloroquine; oral
6.8
27.2
75
142
J45.9
ICD-10 Finland
Asthma, unspecified
4.8
27.1
108
318
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
26.3
26.9
37
16
R52.9
ICD-10 Finland
Pain, unspecified
6.8
26.8
73
136
A02BC02
ATC
pantoprazole; systemic
4.8
26.7
242
1499
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
13.5
26.6
47
41
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
7.0
26.3
70
126
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
6.6
26.0
73
141
R51.80
ICD-10 Finland
Headache
4.9
26.0
99
276
N06AX11
ATC
mirtazapine; oral
3.9
25.9
156
669
M54.5
ICD-10 Finland
Low back pain
3.8
25.6
159
698
A01
ICPC
Pain general/multiple sites
6.9
25.2
68
124
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.7
25.0
69
130
SAA01
NOMESCO Finland
Simple examination of mouth
5.9
24.8
263
1820
A06AC01
ATC
ispaghula (psylla seeds); oral
4.0
24.4
130
494
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
16.5
24.2
39
27
A02BC03
ATC
lansoprazole; oral
3.9
24.1
135
535
M01AH01
ATC
celecoxib; oral (coxibs)
4.3
23.4
104
333
M03BC01
ATC
orphenadrine (citrate); systemic
3.7
23.3
137
560
SAA02
NOMESCO Finland
Basic examination of mouth
4.5
23.2
246
1621
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.8
22.8
130
516
N03AE01
ATC
clonazepam; systemic
8.0
22.8
54
81
L28
ICPC
Limited function/disability (L)
5.2
22.0
76
186
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.9
22.0
116
428
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
5.7
21.8
68
148
AA1AD
NOMESCO Finland
CT of head and brain
4.5
21.8
89
260
R42
ICD-10 Finland
Dizziness and giddiness
4.2
21.6
98
316
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.4
21.6
172
873
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
5.2
21.2
72
173
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
5.9
21.1
63
130
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
3.6
20.9
127
520
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.1
20.8
72
176
M70.6
ICD-10 Finland
Trochanteric bursitis
4.6
20.8
82
230
M35.7
ICD-10 Finland
Hypermobility syndrome
16.8
20.8
33
22
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.8
20.8
78
208
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
35.5
20.6
26
8
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
6.0
20.5
60
120
F34.1
ICD-10 Finland
Dysthymia
8.7
20.3
45
60
N05AH04
ATC
quetiapine; oral
4.1
20.2
92
295
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
20.0
146
682
A02BC01
ATC
omeprazole; systemic
3.5
20.0
123
505
R07.4
ICD-10 Finland
Chest pain, unspecified
3.7
20.0
110
412
N02AA05
ATC
oxycodone; systemic
5.2
19.8
67
159
N03AX09
ATC
lamotrigine; oral
7.6
19.8
48
74
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
5.8
19.5
59
123
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
7.4
19.4
48
76
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
3.2
19.3
197
1157
R03AC02
ATC
salbutamol; inhalant
3.3
19.3
209
1280
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
5.1
19.1
65
155
N06AB04
ATC
citalopram; systemic
3.4
18.9
119
494
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.8
18.9
57
118
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.9
18.8
92
312
M03BX02
ATC
tizanidine; oral
3.7
18.8
240
1646
G43.9
ICD-10 Finland
Migraine, unspecified
5.5
18.5
58
126
L03
ICPC
Low back symptom/complaint
3.4
18.4
114
466
N05BA01
ATC
diazepam; systemic, rectal
4.5
18.3
72
199
G50.0
ICD-10 Finland
Trigeminal neuralgia
18.1
18.3
28
17
M01AH05
ATC
etoricoxib; oral
3.3
18.2
225
1483
N02BE01
ATC
paracetamol; systemic, rectal
7.7
18.2
278
2216
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.4
18.1
58
129
N05BA04
ATC
oxazepam; oral
3.3
17.9
119
509
M54.6
ICD-10 Finland
Pain in thoracic spine
5.7
17.8
54
112
UJF32
NOMESCO Finland
Coloscopy
3.4
17.8
107
424
R02
ICPC
Shortness of breath/dyspnoea
4.8
17.7
64
162
N06AB10
ATC
escitalopram; oral
3.3
17.6
112
461
A03FA01
ATC
metoclopramide; systemic, rectal
3.4
17.5
106
421
M47.82
ICD-10 Finland
Other spondylosis, cervical region
11.1
17.4
33
33
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.1
17.2
124
559
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.6
17.2
94
345
R03DC03
ATC
montelukast; oral
3.5
17.0
95
355
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
7.4
16.9
41
63
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
4.0
16.9
76
237
N06AB06
ATC
sertraline; oral
4.3
16.8
69
198
M53.0
ICD-10 Finland
Cervicocranial syndrome
4.4
16.7
65
177
L01
ICPC
Neck symptom/complaint
3.7
16.6
84
289
C07AB07
ATC
bisoprolol; oral
2.9
16.5
140
698
M03BC51
ATC
orphenadrine, combinations; systemic
3.0
16.5
136
665
R53
ICD-10 Finland
Malaise and fatigue
3.4
16.5
95
362
N05CF01
ATC
zopiclone; oral
3.0
16.4
124
573
EB1MA
NOMESCO Finland
Cephalometry with X-ray
14.8
16.4
27
20
J02AC01
ATC
fluconazole; systemic
2.9
16.3
198
1235
M01AX17
ATC
nimesulide; oral
3.2
16.3
106
440
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.9
16.2
47
92
N02AJ06
ATC
codeine and paracetamol; systemic
2.9
16.2
150
787
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
4.2
16.0
66
189
-1
NOMESCO Finland
NA
2.9
16.0
144
739
L17
ICPC
Foot/toe symptom/complaint
3.1
16.0
110
474
J01FF01
ATC
clindamycin; systemic
3.1
15.9
115
513
R13
ICD-10 Finland
Dysphagia
6.6
15.9
42
73
A02BA02
ATC
ranitidine; systemic
3.5
15.9
86
312
SPAT1216
SPAT
Assessment of functional ability
4.3
15.6
62
172
H04.10
ICD-10 Finland
Dry eye syndrome
4.2
15.5
63
178
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
3.3
15.5
93
361
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.0
15.5
52
121
M01AE03
ATC
ketoprofen; systemic, rectal
2.8
15.4
145
762
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
8.4
15.4
34
45
N05CF02
ATC
zolpidem; oral
3.4
15.4
89
335
Z01.2
ICD-10 Finland
Dental examination
2.8
15.4
164
929
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
4.3
15.4
62
174
SXC05
NOMESCO Finland
Other oral or dental procedure
5.9
15.3
44
85
Z71.8
ICD-10 Finland
Other specified counselling
3.0
15.3
112
501
SPAT1312
SPAT
General health counselling
2.9
15.2
128
628
R01AD09
ATC
mometasone; nasal
2.8
15.2
186
1143
M53.1
ICD-10 Finland
Cervicobrachial syndrome
3.8
15.1
72
234
G54.0
ICD-10 Finland
Brachial plexus disorders
10.0
15.1
30
33
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
5.7
15.1
45
91
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
8.3
14.9
33
44
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
8.3
14.9
33
44
N06AA10
ATC
nortriptyline; systemic
12.9
14.9
26
22
N39.4
ICD-10 Finland
Other specified urinary incontinence
4.7
14.9
53
131
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
9.7
14.9
30
34
E0000UV
ATC
NA
2.7
14.9
156
870
M54.2
ICD-10 Finland
Cervicalgia
4.8
14.8
52
127
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.0
14.7
49
113
K07.4
ICD-10 Finland
Malocclusion, unspecified
16.5
14.7
23
15
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
4.9
14.7
50
118
M01AC06
ATC
meloxicam; systemic, rectal
2.7
14.6
152
841
C07AA05
ATC
propranolol; systemic
3.0
14.5
101
434
M03BX01
ATC
baclofen; systemic
12.9
14.4
25
21
F41.1
ICD-10 Finland
Generalized anxiety disorder
5.7
14.4
42
83
L13
ICPC
Hip symptom/complaint
3.7
14.3
70
232
H02AB04
ATC
methylprednisolone; systemic
3.5
14.3
75
260
K08.80
ICD-10 Finland
Toothache NOS
4.4
14.3
55
147
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.7
14.2
193
1234
R96
ICPC
Asthma
4.7
14.2
51
127
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
5.2
14.2
45
98
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
13.7
14.2
24
19
R5140
NOMESCO Finland
Monitoring the use of the aid
4.4
14.1
54
143
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
14.1
104
463
N06AX12
ATC
bupropion; oral
4.9
14.1
48
113
P01AB01
ATC
metronidazole; oral, rectal
2.6
14.1
171
1024
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.7
14.1
204
1354
K07.62
ICD-10 Finland
Habitual dislocation of the jaw joint
21.4
14.0
20
10
R51.81
ICD-10 Finland
Facial pain NOS
8.7
14.0
30
38
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.6
13.9
69
231
K07.13
ICD-10 Finland
Retrognaty, mandibular
13.0
13.9
24
20
N02AC04
ATC
dextropropoxyphene; oral
11.8
13.8
25
23
UKC02
NOMESCO Finland
Cystoscopy
4.4
13.8
52
136
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
7.3
13.7
33
50
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.3
13.7
53
142
EGA05
NOMESCO Finland
Rinsing of mandipular joint
+∞
13.6
13
*
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
2.7
13.6
208
1409
WX002
NOMESCO Finland
Sedation and analgesia
3.3
13.6
78
291
EGA00
NOMESCO Finland
Arthroscopy of mandibular joint
146.6
13.6
14
*
G43.3
ICD-10 Finland
Complicated migraine
11.3
13.5
25
24
R06AX27
ATC
desloratadine; oral
2.7
13.5
128
659
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
5.6
13.4
40
81
SPAT1284
SPAT
Extensive health certificate
9.0
13.4
28
34
WX110
NOMESCO Finland
Local anesthesy
2.9
13.3
235
1724
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.7
13.3
63
203
N01
ICPC
Headache
3.7
13.2
63
204
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.2
13.1
79
304
M01AB08
ATC
etodolac; oral
4.8
13.1
45
107
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
2.8
13.0
111
534
SPAT1263
SPAT
Sampling
2.5
13.0
152
877
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.9
12.9
57
172
SPAT1254
SPAT
Administration of medicine
3.9
12.9
57
172
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
16.4
12.8
20
13
M54.9
ICD-10 Finland
Dorsalgia, unspecified
3.6
12.7
63
210
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.7
12.6
115
575
R21
ICPC
Throat symptom/complaint
2.8
12.5
102
474
M02AA07
ATC
piroxicam; topical
2.5
12.5
136
748
J01AA02
ATC
doxycycline; systemic
3.4
12.5
256
2011
SPAT1240
SPAT
Therapeutic discussion
3.5
12.5
64
219
A07EC01
ATC
sulfasalazine; oral, rectal
4.1
12.4
51
144
XA800
NOMESCO Finland
Neuropsychological investigation
6.8
12.4
31
50
P03
ICPC
Feeling depressed
3.7
12.3
57
179
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
4.7
12.3
43
104
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
7.4
12.3
29
43
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.9
12.2
53
158
WZA90
NOMESCO Finland
Other doctors statement
2.8
12.2
98
453
L04AB04
ATC
adalimumab; parenteral
9.0
12.1
25
30
SPAT1360
SPAT
Extensive global examination
4.9
12.0
40
92
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
5.4
11.9
36
74
Z50.1
ICD-10 Finland
Other physical therapy
6.2
11.9
32
57
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
6.4
11.9
31
53
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.8
11.9
40
93
L08
ICPC
Shoulder symptom/complaint
3.0
11.8
79
324
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
2.5
11.8
118
616
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.5
11.8
60
203
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.8
11.8
53
162
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.2
11.8
69
259
M54.1
ICD-10 Finland
Radiculopathy
7.3
11.8
28
42
EG1CG
NOMESCO Finland
Extensive MRI examination of mandipular joint with high intensity magnet
31.5
11.8
15
5
K07.23
ICD-10 Finland
Deep bite
11.8
11.7
21
19
R01BA52
ATC
pseudoephedrine, combinations; oral
2.5
11.7
132
732
SPAT1153
SPAT
Removal of sutures
2.6
11.7
106
523
C07AB02
ATC
metoprolol; systemic
3.2
11.7
68
254
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.7
11.6
40
95
M50.3
ICD-10 Finland
Other cervical disc degeneration
8.4
11.6
25
32
P01
ICPC
Feeling anxious/nervous/tense
3.3
11.6
63
223
L88
ICPC
Rheumatoid/seropositive arthritis
6.0
11.6
32
59
R03BA02
ATC
budesonide; inhalant
2.9
11.5
80
335
A03CA02
ATC
clidinium and psycholeptics; oral
5.2
11.5
36
77
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
5.7
11.5
33
64
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
10.3
11.5
22
23
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
8.2
11.4
25
33
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.4
11.4
42
107
L15
ICPC
Knee symptom/complaint
2.8
11.4
83
360
EG1AA
NOMESCO Finland
Mandibular joint X-ray examination
36.6
11.4
14
*
M48.0
ICD-10 Finland
Spinal stenosis
4.1
11.4
45
123
H01
ICPC
Ear pain/earache
3.6
11.4
55
179
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.0
11.2
47
135
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.1
11.2
67
255
N06AB03
ATC
fluoxetine; oral
3.1
11.1
67
256
J01FA10
ATC
azithromycin; systemic
2.5
11.1
216
1568
R05
ICD-10 Finland
Cough
2.8
11.1
81
351
R06.0
ICD-10 Finland
Dyspnoea
2.8
11.0
85
378
R06AE07
ATC
cetirizine; oral
2.3
11.0
172
1114
A06AD11
ATC
lactulose; oral
3.8
11.0
49
149
K07.6
ICD-10 Finland
Temporomandibular joint disorders
16.3
11.0
17
11
N06AX03
ATC
mianserin; oral
6.0
10.9
30
55
K07.61
ICD-10 Finland
Cracking jaw joint
8.1
10.9
24
32
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.1
10.9
34
73
M01AB05
ATC
diclofenac; systemic, rectal
2.6
10.8
226
1689
M01AH02
ATC
rofecoxib; oral
3.4
10.8
58
201
SPAT1301
SPAT
No procedures
2.5
10.8
107
550
3007
Kela drug reimbursment
Erenumab and fremanezumab
13.6
10.8
18
14
F45.0
ICD-10 Finland
Somatization disorder
22.5
10.8
15
7
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
3.3
10.8
58
202
R07.0
ICD-10 Finland
Pain in throat
4.2
10.8
42
113
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
6.1
10.8
29
52
J31.0
ICD-10 Finland
Chronic rhinitis
3.9
10.7
46
135
J01FA09
ATC
clarithromycin; systemic
2.4
10.7
131
750
R03BA08
ATC
ciclesonide; inhalant
3.7
10.7
48
147
SPAT1229
SPAT
Assessment of need for aid
4.8
10.6
35
80
F32
ICD-10 Finland
Depressive episode
4.6
10.5
37
90
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.7
10.5
47
143
TEG00
NOMESCO Finland
Punction of mandibular joint
114.0
10.5
11
*
R03AK08
ATC
formoterol and beclometasone; inhalant
5.6
10.5
30
58
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
16.8
10.5
16
10
N06AX26
ATC
vortioxetine; oral
4.5
10.4
37
91
K02.1
ICD-10 Finland
Caries of dentine
2.3
10.4
194
1352
R09
ICPC
Sinus symptom/complaint
3.6
10.4
49
156
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
5.6
10.3
30
59
A04
ICPC
Weakness/tiredness general
3.3
10.2
55
192
J01DA01
ATC
[U] cefalexin; systemic
2.4
10.1
211
1539
N06AX22
ATC
agomelatine; oral
6.7
10.1
25
40
M01AG02
ATC
tolfenamic acid; oral, rectal
2.6
10.1
87
411
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.6
10.1
35
84
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.4
10.1
37
94
M01AE02
ATC
naproxen; oral, rectal
2.3
10.1
204
1468
N06AX05
ATC
trazodone; oral
7.5
10.0
23
33
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.8
10.0
72
306
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.2
10.0
178
1204
M13.9
ICD-10 Finland
Arthritis, unspecified
4.2
10.0
38
100
D06
ICPC
Abdominal pain localized other
3.7
10.0
45
138
N03AX11
ATC
topiramate; oral
7.0
10.0
24
37
A01AB09
ATC
miconazole; local oral
3.6
9.9
46
144
N02CD03
ATC
fremanezumab; systemic
27.1
9.9
13
5
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
8.3
9.8
21
27
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.0
9.8
62
243
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
8.9
9.7
20
24
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.8
9.7
70
296
J01DB01
ATC
cefalexin; oral
2.9
9.7
255
2081
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.6
9.7
33
78
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
10.6
9.7
18
18
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.5
9.7
34
83
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
4.4
9.7
35
88
SPAT1260
SPAT
Consultation of another employee
2.9
9.6
64
258
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
5.3
9.6
29
60
R03BB04
ATC
tiotropium bromide; inhalant
4.1
9.6
38
104
A02BA04
ATC
nizatidine; systemic
4.1
9.6
37
99
H53.1
ICD-10 Finland
Subjective visual disturbances
4.3
9.5
35
89
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
5.6
9.5
27
52
N03AG01
ATC
valproic acid; systemic, rectal
4.8
9.5
31
70
K03.00
ICD-10 Finland
Approximal wear
5.2
9.5
29
61
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
9.4
72
317
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
11.2
9.4
17
16
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
7.7
9.4
21
29
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
3.3
9.4
51
178
J01MA02
ATC
ciprofloxacin; systemic
2.3
9.4
123
714
R06.5
ICD-10 Finland
Mouth breathing
4.1
9.4
36
96
D07AB02
ATC
hydrocortisone butyrate; topical
2.3
9.3
106
577
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.2
9.3
140
866
NA1AD
NOMESCO Finland
Cervical spine CT examination
8.8
9.2
19
23
L29
ICPC
Musculoskeletal sympt/complt other
3.9
9.2
38
108
R1250
NOMESCO Finland
Evaluation of functional capability
9.5
9.2
18
20
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.0
9.2
58
225
D07AC01
ATC
betamethasone; topical
2.2
9.1
119
690
R20.2
ICD-10 Finland
Paraesthesia of skin
3.8
9.0
38
110
J45.1
ICD-10 Finland
Nonallergic asthma
3.9
9.0
37
105
H92.0
ICD-10 Finland
Otalgia
4.3
8.9
33
85
TAB00
NOMESCO Finland
Lumbar puncture
5.4
8.9
26
52
R03AK07
ATC
formoterol and budesonide; inhalant
2.5
8.9
82
398
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
4.8
8.8
29
66
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.7
8.8
68
298
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
4.1
8.8
34
91
L86
ICPC
Back syndrome with radiating pain
4.1
8.8
34
91
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
3.1
8.8
49
176
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
14.6
8.8
14
10
SPAT1249
SPAT
Treatment-related counselling outside office
2.2
8.8
135
836
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
3.1
8.8
50
183
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.4
8.8
90
464
EBA10
NOMESCO Finland
Surgical removal of tooth
2.9
8.8
56
219
R00.2
ICD-10 Finland
Palpitations
3.6
8.7
40
125
D82
ICPC
Teeth/gum disease
2.2
8.6
126
763
M01AB55
ATC
diclofenac, combinations; oral
4.0
8.6
34
93
P76
ICPC
Depressive disorder
3.5
8.6
40
126
H03AA01
ATC
levothyroxine sodium; systemic
2.3
8.6
99
537
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
3.0
8.6
52
198
L11
ICPC
Wrist symptom/complaint
3.3
8.5
44
150
R35
ICD-10 Finland
Polyuria
5.6
8.5
24
46
D02
ICPC
Abdominal pain epigastric
4.1
8.5
33
89
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.1
8.5
26
55
KMAK
NOMESCO Finland
NA
2.1
8.5
183
1302
E66.01
ICD-10 Finland
Obesity due to excess calories
3.3
8.5
44
151
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
92.7
8.5
9
*
B01AC04
ATC
clopidogrel; oral
3.9
8.4
34
95
NH3EA
NOMESCO Finland
Feet X-ray examination with load
7.5
8.4
19
27
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
7.5
8.4
19
27
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.1
8.4
123
742
R50.9
ICD-10 Finland
Fever, unspecified
2.9
8.4
52
201
S01GX01
ATC
cromoglicic acid; ophthalmic
2.3
8.4
93
495
R4120
NOMESCO Finland
Occupational therapy
4.2
8.4
31
80
N03AF01
ATC
carbamazepine; oral, rectal
5.0
8.4
26
56
C09CA06
ATC
candesartan; oral
2.5
8.4
77
372
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.8
8.3
27
61
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.1
8.3
47
171
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
4.1
8.3
32
86
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.6
8.3
37
113
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
4.2
8.3
31
81
J01MA12
ATC
levofloxacin; systemic
2.7
8.3
60
255
M01AB01
ATC
indometacin; systemic, rectal
4.9
8.2
26
57
NF1AA
NOMESCO Finland
Hip X-ray examination
3.8
8.2
34
97
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
3.7
8.2
36
108
R03BA01
ATC
beclometasone; inhalant
2.7
8.2
59
248
M01AE51
ATC
ibuprofen, combinations; systemic
12.2
8.2
14
12
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
2.1
8.2
154
1029
A06AC51
ATC
ispaghula, combinations; systemic
4.2
8.2
30
77
SBA10
NOMESCO Finland
Measurement of excretion of saliva
10.5
8.1
15
15
L16
ICPC
Ankle symptom/complaint
3.0
8.0
47
175
R03AC12
ATC
salmeterol; inhalant
5.7
8.0
22
41
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.9
8.0
49
187
ZXA00
NOMESCO Finland
Right side
2.3
8.0
81
411
N02CC06
ATC
eletriptan; oral
4.5
8.0
27
64
C01CA24
ATC
epinephrine; parenteral
3.6
8.0
36
111
H02AB07
ATC
prednisone; oral
2.7
8.0
58
246
S03.0
ICD-10 Finland
Dislocation of jaw
13.5
8.0
13
10
K30
ICD-10 Finland
Functional dyspepsia
3.0
8.0
48
180
J01FA15
ATC
telithromycin; oral
3.0
8.0
48
180
L04AA13
ATC
leflunomide; oral
5.3
7.9
23
46
J01FA06
ATC
roxithromycin; oral
2.0
7.9
145
952
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
3.0
7.9
46
171
SDA02
NOMESCO Finland
Parodonthologic therapy
2.1
7.9
120
733
S29
ICPC
Skin symptom/complaint other
2.6
7.9
63
282
K07.68
ICD-10 Finland
Other disorders of the jaw joint
11.2
7.9
14
13
A07AA02
ATC
nystatin; oral
4.0
7.9
31
85
XA402
NOMESCO Finland
ENMG
6.7
7.9
19
30
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
2.0
7.9
179
1283
R01AD12
ATC
fluticasone furoate; nasal
2.1
7.8
124
769
M01AX01
ATC
nabumetone; oral
4.5
7.8
27
65
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
6.2
7.8
20
34
R01AD08
ATC
fluticasone; nasal
2.1
7.8
118
717
D07AA02
ATC
hydrocortisone; topical
2.7
7.8
57
241
SPAT1310
SPAT
Counselling related to known health issue
2.1
7.8
106
616
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
5.2
7.8
23
47
SPAT1097
SPAT
Recording of ECG
2.8
7.8
51
203
SGC00
NOMESCO Finland
Local medication of root channels of tooth
2.8
7.8
52
211
C08CA01
ATC
amlodipine; oral
2.3
7.8
84
441
C03CA01
ATC
furosemide; systemic
2.6
7.7
62
277
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
6.5
7.7
19
31
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
9.2
7.6
15
17
D01
ICPC
Abdominal pain/cramps general
2.8
7.6
50
198
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
3.1
7.6
42
148
JAH01
NOMESCO Finland
Laparoscopy
4.1
7.6
29
77
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
10.4
7.6
14
14
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.8
7.6
53
218
WX290
NOMESCO Finland
Other blockade of nerve
2.0
7.6
155
1056
F43.1
ICD-10 Finland
Post-traumatic stress disorder
5.3
7.6
22
44
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.5
7.6
66
309
N04BC05
ATC
pramipexole; oral
4.0
7.5
29
78
N03AF02
ATC
oxcarbazepine; oral
5.9
7.5
20
36
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.3
7.5
27
68
ZXA10
NOMESCO Finland
Bilateral
2.5
7.5
61
277
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
7.4
82
433
SDA01
NOMESCO Finland
Simple parodonthologic therapy
2.2
7.4
94
527
S06.0
ICD-10 Finland
Concussion
3.2
7.4
39
135
G04BD12
ATC
mirabegron; oral
3.4
7.4
35
112
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.0
7.4
42
153
X58
ICD-10 Finland
Exposure to other specified factors
2.7
7.4
53
224
R01AD11
ATC
triamcinolone; nasal
2.8
7.4
47
185
SJB60
NOMESCO Finland
External device grinding and adaptation
11.3
7.4
13
12
H02AB09
ATC
hydrocortisone; systemic
6.5
7.4
18
29
N02CC03
ATC
zolmitriptan; nasal, oral
3.2
7.4
39
136
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
2.0
7.3
166
1174
R11
ICD-10 Finland
Nausea and vomiting
3.6
7.3
32
96
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
16.3
7.3
11
7
J01EA01
ATC
trimethoprim; systemic
2.1
7.3
101
589
R07.3
ICD-10 Finland
Other chest pain
3.1
7.3
40
141
Z00.0
ICD-10 Finland
General medical examination
2.4
7.2
64
301
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
5.6
7.2
20
38
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
2.9
7.2
45
174
S18
ICPC
Laceration/cut
2.0
7.2
117
727
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.0
7.2
28
76
H93.1
ICD-10 Finland
Tinnitus
3.7
7.2
31
92
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
4.1
7.2
27
71
F60.5
ICD-10 Finland
Anankastic personality disorder
8.3
7.2
15
19
R74
ICPC
Upper respiratory infection acute
2.0
7.2
118
735
TEG10
NOMESCO Finland
Injection of diagnostic or therapeutic substance into mandibular joint
30.8
7.2
9
*
N06AX17
ATC
milnacipran; oral
12.5
7.1
12
10
JN3AD
NOMESCO Finland
Abdominal CT examination
3.8
7.1
29
82
C05AA08
ATC
fluocortolone; rectal, topical
2.5
7.1
57
256
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
5.2
7.1
21
43
XKD06
NOMESCO Finland
Physiologic investigation of micturition
9.1
7.1
14
16
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.1
7.1
97
561
L02
ICPC
Back symptom/complaint
2.9
7.1
44
169
K02
ICPC
Pressure/tightness of heart
7.3
7.1
16
23
EMAK
NOMESCO Finland
NA
4.3
7.1
25
62
L12
ICPC
Hand/finger symptom/complaint
2.5
7.1
57
257
WZA00
NOMESCO Finland
Short statement of of health and health related matters
3.7
7.1
30
88
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.7
7.1
48
196
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
4.9
7.1
22
48
R03AC03
ATC
terbutaline; inhalant
2.4
7.1
61
285
L99
ICPC
Musculoskeletal disease other
6.6
7.1
17
27
M35.3
ICD-10 Finland
Polymyalgia rheumatica
6.1
7.0
18
31
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.1
7.0
39
139
XQ800
NOMESCO Finland
Prick test
3.0
7.0
41
153
SPF40
NOMESCO Finland
Removal and reattachment with cement of tooth crone or short bridge
7.8
7.0
15
20
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.4
7.0
33
106
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.2
7.0
84
459
M89.0
ICD-10 Finland
Algoneurodystrophy
14.2
6.9
11
8
SXC03
NOMESCO Finland
Other oral or dental procedure
14.2
6.9
11
8
TEA00
NOMESCO Finland
Biopsy of lip
14.2
6.9
11
8
R03BA05
ATC
fluticasone; inhalant
2.3
6.9
71
361
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
8.6
6.9
14
17
R00.0
ICD-10 Finland
Tachycardia, unspecified
4.5
6.9
23
54
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
6.9
60
281
C08DA01
ATC
verapamil; systemic
6.4
6.9
17
28
C10AA05
ATC
atorvastatin; oral
2.1
6.9
87
486
K04.1
ICD-10 Finland
Necrosis of pulp
2.8
6.9
46
185
J37.0
ICD-10 Finland
Chronic laryngitis
5.2
6.8
20
41
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
7.5
6.8
15
21
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
41.0
6.8
8
*
M54.3
ICD-10 Finland
Sciatica
3.5
6.8
31
97
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.8
6.8
43
169
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.0
6.8
39
144
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.6
6.7
49
208
M54
ICD-10 Finland
Dorsalgia
2.6
6.7
51
220
SBA00
NOMESCO Finland
Microbiological examinations
5.7
6.7
18
33
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
5.7
6.7
18
33
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.8
6.7
43
170
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.9
6.7
26
71
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.8
6.6
42
164
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
6.6
41
156
L04AB06
ATC
golimumab; parenteral
12.6
6.6
11
9
E000003
ATC
NA
3.8
6.6
27
77
A29
ICPC
General symptom/complaint other
2.9
6.6
41
157
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
7.1
6.6
15
22
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
10.4
6.6
12
12
SPAT1305
SPAT
Counselling and guidance related to physical exercise
3.2
6.6
33
111
K80
ICPC
Cardiac arrhythmia NOS
3.1
6.5
36
127
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
6.5
128
847
N05CD07
ATC
temazepam; oral
3.0
6.5
37
135
L04
ICPC
Chest symptom/complaint
3.8
6.5
26
73
J01CA08
ATC
pivmecillinam; oral
1.9
6.5
160
1145
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
7.7
6.5
14
19
M77.1
ICD-10 Finland
Lateral epicondylitis
2.9
6.5
40
152
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
6.5
163
1174
F45.1
ICD-10 Finland
Undifferentiated somatoform disorder
71.4
6.5
7
*
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
2.7
6.4
44
180
R30.0
ICD-10 Finland
Dysuria
5.4
6.4
18
35
SPAT1234
SPAT
Support of social functional capacity
5.4
6.4
18
35
EBB10
NOMESCO Finland
Insertion of dental implant
8.4
6.4
13
16
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
6.2
6.4
16
27
L05
ICPC
Flank/axilla symptom/complaint
4.0
6.4
24
64
N06AA12
ATC
doxepin; systemic
4.0
6.4
24
64
N81.6
ICD-10 Finland
Rectocele
3.0
6.3
36
131
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.7
6.3
43
174
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.3
6.3
65
329
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
18.5
6.3
9
5
M15.8
ICD-10 Finland
Other polyarthrosis
7.3
6.3
14
20
A02BC04
ATC
rabeprazole; oral
2.7
6.3
41
164
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.0
6.3
36
132
D07AC13
ATC
mometasone; topical
2.0
6.3
97
583
RF421
NOMESCO Finland
NA
27.3
6.3
8
*
G50.8
ICD-10 Finland
Other disorders of trigeminal nerve
27.3
6.3
8
*
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.9
6.3
126
835
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.2
6.2
22
55
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
2.8
6.2
39
150
SPAT1211
SPAT
Application of soft bandage
3.0
6.2
35
126
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.6
6.2
48
209
H02
ICPC
Hearing complaint
3.1
6.2
32
110
XF402
NOMESCO Finland
ECG with work load test
3.1
6.2
33
116
E66.8
ICD-10 Finland
Other obesity
3.4
6.2
29
93
R49.01
ICD-10 Finland
Functional dysphonia
4.6
6.2
20
46
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.5
6.2
27
82
J45
ICD-10 Finland
Asthma
2.6
6.2
45
190
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
5.1
6.2
18
37
R5599
NOMESCO Finland
Other rehabilitation service
5.1
6.2
18
37
SPAT1252
SPAT
Overall medication plan or its review
3.9
6.2
24
66
N02CC04
ATC
rizatriptan; oral
2.9
6.2
37
141
WZC30
NOMESCO Finland
Teaching
2.6
6.2
46
199
XG474
NOMESCO Finland
Exhalation nntrogen oxide
4.4
6.2
21
51
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
4.0
6.1
23
61
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
4.0
6.1
23
61
N06AB05
ATC
paroxetine; oral
3.2
6.1
31
105
F32.1
ICD-10 Finland
Moderate depressive episode
3.1
6.1
32
111
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.2
6.1
66
342
R06AX26
ATC
fexofenadine; oral
2.8
6.1
39
153
M03AX01
ATC
botulinum toxin; parenteral
12.9
6.1
10
8
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
10.3
6.1
11
11
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
10.3
6.1
11
11
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
10.3
6.1
11
11
XF404
NOMESCO Finland
Ambulatory ECG
3.1
6.1
32
112
R06AE09
ATC
levocetirizine; oral
2.2
6.1
63
319
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.3
6.0
21
52
M01AC01
ATC
piroxicam; systemic, rectal
2.6
6.0
45
194
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.6
6.0
26
78
WX723
NOMESCO Finland
CPAP therapy
5.0
6.0
18
38
ZXA05
NOMESCO Finland
Left side
2.1
6.0
71
383

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
180
600
5.43
51.96
1.6
1.3
iu/ml
31.4
30.1
0.04
46
198
(3037522) Nuclear Ab [Titer] in Serum
156
466
5.48
51.26
1.9
1.4
titre
334.4
551.0
1.24
36
102
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
176
604
5.13
48.28
1.6
1.3
u/ml
18.9
15.0
0.21
69
256
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
187
730
4.63
42.10
2.7
2.0
u/l
89.2
226.4
0.94
178
702
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
239
1210
4.59
35.75
6.4
6.3
mmol/l
1.2
1.2
0.19
207
1040
(3001604) Monocytes [#/volume] in Blood
256
1382
4.88
34.57
8.0
5.6
e9/l
0.5
0.5
0.10
239
1220
(3006315) Basophils [#/volume] in Blood
255
1389
4.76
33.59
8.3
5.5
e9/l
0.0
0.0
1.62
238
1223
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
202
942
3.98
33.16
2.3
1.8
pmol/l
97.8
98.6
0.10
104
469
(3019198) Lymphocytes [#/volume] in Blood
256
1423
4.64
32.15
8.2
5.6
e9/l
2.1
2.0
0.23
242
1287
(3036481) Cortisol [Moles/volume] in Serum or Plasma
99
285
4.54
32.14
2.6
2.0
nmol/l
318.9
370.0
1.95
89
268
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
312
2060
11.55
30.88
10.5
6.8
u/l
73.9
74.8
0.21
303
1947
(3013115) Eosinophils [#/volume] in Blood
256
1447
4.50
30.79
8.4
5.9
e9/l
0.2
0.2
1.83
244
1300
(3037467) Urinalysis macro (dipstick) panel - Urine
296
1877
6.91
30.34
7.8
4.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
111
366
4.07
29.77
1.9
1.6
nmol/l
1130.9
1188.2
0.26
89
278
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
229
1220
3.91
29.54
3.2
2.3
nmol/l
77.1
76.3
0.17
214
1125
(3013707) Erythrocyte sedimentation rate by Westergren method
312
2091
11.09
29.50
9.3
3.9
mm/h
11.5
10.1
1.11
302
1954
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
213
1084
3.75
29.46
5.8
5.6
mmol/l
1.2
1.2
0.47
199
1002
(3031040) Bacteria [#/volume] in Urine by Automated count
285
1775
5.62
29.26
6.9
4.0
e6/l
162.0
582.9
—
6
24
(3022096) Basophils/100 leukocytes in Blood
231
1246
3.89
29.05
8.7
5.6
%
0.7
0.7
0.05
221
1164
(3019069) Monocytes/100 leukocytes in Blood
237
1303
3.95
28.87
9.0
5.8
%
7.6
8.1
1.83
230
1233
(3006504) Eosinophils/100 leukocytes in Blood
236
1297
3.92
28.70
8.7
5.5
%
3.0
2.7
0.85
229
1218
(42870588) Differential panel, method unspecified - Blood
186
881
3.57
28.54
7.7
5.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
146
597
3.61
28.21
2.6
2.1
mg/l
2.5
2.9
1.67
134
514
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
172
786
3.50
27.75
3.4
2.4
u/l
49.0
56.1
2.31
161
735
(3002030) Lymphocytes/100 leukocytes in Blood
239
1342
3.88
27.72
8.8
5.6
%
30.9
29.6
1.25
231
1262
(40768797) Stomach Pathology biopsy report
109
373
3.88
27.47
1.4
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
264
1604
4.31
26.73
9.9
9.0
e9/l
3.9
3.9
0.01
248
1419
(3032080) INR in Blood by Coagulation assay
178
845
3.42
26.73
7.4
6.1
inr
1.2
1.1
0.61
71
276
(3018010) Neutrophils/100 leukocytes in Blood
235
1324
3.73
26.68
8.7
5.4
%
55.3
56.5
1.08
226
1255
(3018418) pH of Serum or Plasma
164
743
3.41
26.55
3.3
3.6
ph
7.4
7.4
0.36
41
133
(3013826) Glucose [Moles/volume] in Serum or Plasma
245
1436
3.79
25.73
5.6
4.3
mmol/l
6.2
6.4
0.92
231
1323
(3024561) Albumin [Mass/volume] in Serum or Plasma
195
1005
3.32
25.05
4.1
4.1
g/l
36.9
36.6
0.50
181
956
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
173
835
3.27
24.77
3.6
2.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
231
1345
3.43
23.63
5.8
5.6
umol/l
8.2
9.5
3.91
220
1279
(3015377) Calcium [Moles/volume] in Serum or Plasma
176
879
3.16
23.40
2.6
3.1
mmol/l
2.4
2.4
0.48
159
790
(3002582) Erythrocytes [#/volume] in Urine
151
707
3.10
22.21
3.5
2.7
e6/l
41.7
75.7
0.45
122
533
(3026782) Osmolality of Urine
112
455
3.22
20.85
3.0
2.3
mosm/kgh2o
500.0
531.1
0.75
89
392
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
166
843
2.96
20.76
4.3
3.1
ng/l
22.0
22.4
0.01
95
467
(3000850) Epithelial cells [#/volume] in Urine
117
490
3.16
20.65
3.0
2.2
e6/l
6.0
8.7
0.71
105
436
(36304419) Bacteria [Presence] in Urine
139
644
3.01
20.50
3.4
2.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
149
722
2.95
20.18
1.4
1.3
u/ml
0.6
1.9
1.29
36
211
(3001122) Ferritin [Mass/volume] in Serum or Plasma
226
1386
3.03
19.43
3.9
2.8
ug/l
78.3
75.6
0.16
217
1310
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
328
2834
+∞
19.41
25.1
11.2
mg/l
14.5
19.3
2.85
288
2158
(3035350) Ketones [Presence] in Urine by Test strip
222
1359
2.96
18.95
5.6
3.2
estimate
0.0
0.0
0.00
64
267
(3021960) Folate [Moles/volume] in Serum or Plasma
120
532
2.98
18.90
1.7
1.4
nmol/l
20.0
21.1
0.41
107
454
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
312
2372
7.46
18.47
6.6
4.3
pmol/l
14.3
14.4
0.38
296
2217
(3021601) Nitrite [Presence] in Urine by Test strip
222
1371
2.92
18.42
6.9
4.5
estimate
0.0
0.0
0.00
63
272
(3021440) Promyelocytes/100 leukocytes in Blood
65
201
3.79
18.39
5.2
4.5
%
0.0
0.1
1.90
19
46
(3009261) Glucose [Presence] in Urine by Test strip
223
1382
2.92
18.35
5.7
3.3
estimate
0.0
0.0
0.50
66
267
(3018095) Leukocytes [#/volume] in Urine
167
893
2.77
18.32
4.6
3.2
e6/l
44.9
67.9
0.34
133
586
(3022145) Colonoscopy Study observation
83
303
3.33
18.18
1.4
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
323
2727
13.10
17.86
8.6
5.0
mu/l
1.7
2.2
0.62
309
2561
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
47
117
4.52
17.80
2.2
2.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
66
211
3.66
17.75
2.5
3.4
pmol/l
4.3
4.6
1.85
57
186
(3002179) Metamyelocytes/100 leukocytes in Blood
64
201
3.71
17.66
4.8
4.3
%
0.1
0.7
1.32
15
35
(3025159) Blasts/100 leukocytes in Blood
63
196
3.74
17.63
5.3
4.5
%
0.0
0.2
0.59
17
38
(3017181) Myelocytes/100 leukocytes in Blood
67
218
3.61
17.54
5.0
4.3
%
0.4
0.9
1.00
20
54
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
39
86
5.01
17.07
1.5
1.2
u/ml
58.4
31.8
—
5
9
(3005719) IgG [Mass/volume] in Serum or Plasma
64
208
3.58
16.74
2.3
2.9
g/l
10.0
9.9
0.02
55
197
(3022948) Iron [Moles/volume] in Serum or Plasma
88
349
3.08
16.65
2.1
2.1
umol/l
12.6
14.1
1.42
83
320
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
107
474
2.87
16.56
1.8
1.5
pmol/l
90322990.2
29710600.6
0.29
93
414
(3048689) Calprotectin [Mass/mass] in Stool
94
394
2.94
16.06
2.5
2.0
ug/g
148.7
91.8
0.44
72
307
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
168
945
2.59
16.04
3.4
2.9
u/l
26.4
28.6
1.09
157
905
(3030467) Casts [#/volume] in Urine by Automated count
129
641
2.67
15.87
3.6
2.5
e6/l
0.1
0.4
2.76
103
477
(4010399)
59
194
3.49
15.09
1.6
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
63
219
3.32
14.74
1.7
1.2
u/ml
108.0
227.7
0.56
58
204
(3029937) Albumin [Presence] in Urine by Test strip
138
731
2.53
14.63
6.6
3.4
estimate
0.0
0.0
0.00
64
274
(3012095) Magnesium [Moles/volume] in Serum or Plasma
87
369
2.85
14.38
2.9
3.2
mmol/l
0.8
0.8
0.25
75
355
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
93
409
2.78
14.35
4.8
3.2
ng/l
10.2
297.4
0.93
55
249
(3007164) IgA [Mass/volume] in Serum or Plasma
124
632
2.55
14.19
1.7
1.4
g/l
2.2
2.1
0.06
70
394
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
121
612
2.55
14.05
2.6
1.7
mg/l
0.7
0.8
0.15
87
469
(3026008) Bacteria identified in Urine by Culture
141
770
2.46
13.83
3.3
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
203
1305
2.46
13.80
4.8
3.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
105
508
2.57
13.26
4.5
3.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
70
276
2.95
13.14
2.6
2.1
umol/l
3.9
5.5
1.92
59
241
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
105
513
2.54
12.95
2.6
2.9
ng/l
436.7
756.7
0.91
84
431
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
31
72
4.65
12.70
1.5
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
34
89
4.15
11.97
1.6
1.3
ug/g
392.6
323.6
0.68
17
49
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
85
4.20
11.87
1.6
1.6
iu/ml
0.0
0.0
—
7
7
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
89
420
2.54
11.67
2.5
2.6
mmol/l
2.4
2.4
0.09
77
377
(3007853) Bacteria identified in Skin by Aerobe culture
67
282
2.73
11.02
1.9
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
22
43
5.41
10.94
1.6
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
55
209
2.96
10.93
1.4
1.3
—
39.2
—
0
12
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
305
2516
4.03
10.79
6.4
4.7
mmol/mol
37.8
38.4
0.63
286
2384
(3003327) Ova and parasites identified in Stool by Light microscopy
38
116
3.57
10.78
1.9
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
67
286
2.69
10.70
2.3
2.2
%
21.6
23.2
0.47
56
246
(3024980) IgG subclass 4 [Mass/volume] in Serum
23
48
5.08
10.65
1.8
1.5
g/l
0.9
0.4
1.80
16
39
(3017732) Neutrophils [#/volume] in Blood
54
207
2.93
10.55
3.4
2.5
e9/l
3.4
4.2
2.19
44
175
(3003458) Phosphate [Moles/volume] in Serum or Plasma
63
263
2.73
10.50
2.6
4.4
mmol/l
1.0
1.0
0.60
56
243
(3028026) IgM [Mass/volume] in Serum or Plasma
47
168
3.10
10.37
1.7
1.8
g/l
1.2
1.4
0.42
40
155
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
45
157
3.16
10.34
2.2
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
258
1971
2.45
10.21
4.1
2.8
u/l
39.1
37.5
0.22
242
1886
(3035637) Corticotropin [Mass/volume] in Plasma
18
31
6.09
10.17
1.9
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
65
280
2.65
10.17
1.3
1.2
iu/ml
43.2
160.5
5.41
21
124
(40760892) CBC W Ordered Manual Differential panel - Blood
123
704
2.20
10.15
6.0
4.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
166
1069
2.12
10.09
6.1
3.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
46
166
3.06
9.98
4.7
2.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
40
135
3.24
9.69
2.0
2.2
ug/l
4.1
4.9
0.17
31
121
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
124
725
2.14
9.59
2.0
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
245
1856
2.26
9.48
5.2
3.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
182
1235
2.06
9.38
13.2
8.3
e9/l
0.0
0.0
0.02
163
1014
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
23
54
4.51
9.28
3.2
3.4
%
54.3
58.9
0.80
23
54
(3026493) Urate [Moles/volume] in Serum or Plasma
110
622
2.16
9.21
2.0
2.3
umol/l
301.4
6145.7
2.98
92
560
(3025941) Bacteria identified in Stool by Culture
46
179
2.83
8.70
1.5
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
53
4.38
8.60
3.0
3.0
e9/l
4.0
4.7
0.63
22
53
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
52
218
2.65
8.53
1.9
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
19
7.08
8.50
1.1
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
134
837
2.02
8.45
2.4
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
71
347
2.34
8.39
2.1
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
128
789
2.02
8.36
5.7
2.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
69
336
2.33
8.21
2.9
2.4
e6/l
5.6
4.1
0.23
33
168
(40768443) Skin Pathology biopsy report
34
115
3.18
8.20
1.4
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
17
35
5.07
7.97
2.5
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
313
2730
4.20
7.96
5.3
3.9
mmol/l
5.7
5.7
0.18
295
2562
(3027945) Reticulocytes/100 erythrocytes in Blood
48
200
2.64
7.95
1.9
3.1
%
1.7
1.7
0.03
39
177
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
72
362
2.27
7.93
1.6
1.5
%
1.4
1.3
1.06
63
323
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
52
226
2.55
7.91
2.0
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
24
66
3.84
7.89
1.4
1.7
—
—
—
0
0
(3015736) pH of Urine
159
1076
1.93
7.77
4.6
2.9
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
16
32
5.21
7.74
1.9
1.4
g/l
4.1
2.8
—
9
22
(3024139) IgG subclass 3 [Mass/volume] in Serum
16
32
5.21
7.74
1.9
1.4
g/l
0.3
0.3
—
9
23
(3027135) IgG subclass 1 [Mass/volume] in Serum
16
32
5.21
7.74
1.9
1.4
g/l
5.3
6.1
—
9
23
(3042936) Bacteria identified in Isolate by Culture
67
333
2.27
7.57
2.0
2.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
70
360
2.20
7.26
2.8
2.3
e6/l
0.5
1.2
3.26
34
191
(3011397) Hemoglobin [Presence] in Urine by Test strip
103
613
1.99
7.25
4.7
3.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
41
166
2.68
7.17
1.2
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
36
136
2.85
7.17
1.6
2.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
31
108
3.07
7.12
1.8
1.5
—
—
—
0
0
(3013512) EKG study
110
675
1.95
7.06
4.0
3.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
36
138
2.81
6.98
2.1
3.0
e9/l
70.7
73.5
0.16
31
106
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
88
3.25
6.91
1.4
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
49
4.05
6.81
1.2
1.1
—
—
—
0
0
(4062490)
15
32
4.86
6.76
2.1
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
14
7.34
6.73
1.6
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
63
322
2.18
6.60
2.1
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
48
219
2.40
6.56
1.9
2.3
g/l
0.2
0.2
0.24
42
212
(3003396) Base excess in Arterial blood by calculation
46
206
2.43
6.54
10.0
9.8
mmol/l
1.4
1.2
0.13
34
163
(3045414) Leukocytes [Presence] in Urine
33
126
2.80
6.45
2.2
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
172
1243
1.81
6.43
2.5
2.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
12
22
5.62
6.33
1.3
2.0
%
46.1
50.1
—
7
17
(1616796) Gas panel - Central venous blood
17
43
4.11
6.25
3.0
2.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
18
48
3.91
6.17
1.2
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
50
239
2.29
6.14
4.3
2.1
u/l
33.6
33.0
0.03
44
200
(3019150) Specific gravity of Urine by Refractometry
98
603
1.89
6.11
6.5
3.3
kg/l
1.0
1.0
0.58
17
81
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
58
3.61
6.11
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
49
235
2.28
5.97
5.1
3.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
102
643
1.85
5.87
5.0
3.1
%
100.5
99.9
0.09
97
625
(3047181) Lactate [Moles/volume] in Blood
21
66
3.33
5.70
5.3
14.0
mmol/l
1.2
1.1
0.24
16
57
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
15
37
4.20
5.69
1.1
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
56
3.54
5.67
1.8
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
17
47
3.76
5.56
1.1
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
30
118
2.70
5.55
2.9
3.5
ph
7.4
7.4
—
7
16
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
29
113
2.72
5.47
2.9
3.6
mmol/l
2.6
1.8
0.60
23
84
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
299
2643
2.48
5.45
19.4
9.9
ml/min/173m2
87.9
87.4
0.17
270
2148
(3011288) Drugs identified in Urine by Screen method
23
79
3.06
5.42
2.0
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
38
173
2.35
5.21
2.9
2.1
u/l
460.8
5584.9
1.37
12
69
(40761511) CBC panel - Blood by Automated count
320
2989
3.89
5.11
22.3
10.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
43
209
2.22
5.07
1.3
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
64
365
1.94
4.93
1.6
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
23
84
2.87
4.89
1.4
1.2
u/l
14.5
15.3
0.07
18
65
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
96
624
1.76
4.87
2.3
2.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
90
2.80
4.86
1.3
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
25
97
2.71
4.76
13.9
15.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
36
167
2.30
4.74
1.1
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
110
749
1.71
4.71
2.0
1.7
mmol/l
1.6
1.4
1.42
90
655
(44813793)
12
29
4.26
4.66
1.0
1.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
23
87
2.77
4.59
1.4
1.5
u/l
30.2
29.0
0.05
16
72
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
118
2.50
4.54
2.7
2.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
45
233
2.08
4.53
4.2
2.9
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
17
55
3.21
4.43
1.2
1.0
u/ml
6.8
2.1
—
9
23
(21494755) Public health laboratory ask at order entry panel
13
378
0.32
4.40
1.2
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
45
3.45
4.38
1.4
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
48
258
2.01
4.37
1.5
1.3
iu/l
25.3
29.9
0.45
41
220
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
18
61
3.06
4.35
1.2
1.5
e6/l
2.4
4.9
0.66
13
49
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
31
3.98
4.29
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
31
3.98
4.29
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
31
3.98
4.29
1.4
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
16
51
3.25
4.27
1.3
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
36
3.72
4.25
1.2
1.3
nmol/l
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
41
3.52
4.23
1.2
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
47
254
1.99
4.21
1.3
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
101
692
1.66
4.15
7.0
6.7
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
32
3.85
4.12
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
32
3.85
4.12
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
32
3.85
4.12
1.4
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
10
8.17
4.08
1.3
1.0
%
95.5
96.0
—
8
10
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
10
8.17
4.08
1.3
1.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
9
14
6.57
4.01
1.8
1.1
umol/l
18.1
17.4
—
9
14
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
29
133
2.29
3.93
1.8
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
18
65
2.87
3.92
1.9
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
95
2.53
3.90
1.3
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
26
114
2.39
3.89
1.5
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
83
2.63
3.88
1.3
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
24
102
2.46
3.84
1.8
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
23
96
2.50
3.82
1.3
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
33
162
2.15
3.81
1.2
1.1
—
106.0
—
0
5
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
297
2694
2.08
3.81
4.2
3.5
mmol/l
1.4
1.2
4.72
275
2535
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
17
61
2.88
3.75
1.3
1.2
—
—
—
0
0
(3019225) pH of Specimen
42
228
1.97
3.72
3.5
4.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14
45
3.21
3.69
1.4
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
308
2839
2.39
3.69
5.6
4.3
mmol/l
3.0
2.9
0.41
286
2670
(3021901) Oxygen saturation in Capillary blood
11
30
3.76
3.67
3.7
2.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
40
3.34
3.66
1.2
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
42
230
1.95
3.63
1.3
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
26
118
2.31
3.62
10.5
5.1
mmol/l
25.3
25.1
0.11
26
118
(3009508) Creatinine [Moles/volume] in Urine
101
715
1.60
3.57
3.1
2.8
mmol/l
7.1
7.3
0.11
82
607
(3027315) Oxygen [Partial pressure] in Blood
13
41
3.26
3.53
2.8
2.7
kpa
9.1
9.2
0.16
13
41
(3013290) Carbon dioxide [Partial pressure] in Blood
13
41
3.26
3.53
2.8
2.7
kpa
5.1
5.2
0.06
13
41
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
36
3.42
3.51
1.2
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
12
36
3.42
3.51
3.3
2.2
%
15.2
15.6
—
6
20
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
6
10.15
3.51
1.2
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
93
649
1.60
3.48
1.8
1.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
305
2813
2.20
3.43
5.1
4.0
mmol/l
4.9
4.9
0.07
284
2668
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
22
95
2.41
3.42
1.3
1.1
—
—
—
0
0
(4094501)
18
71
2.62
3.35
1.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
24
109
2.30
3.34
5.2
9.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
29
143
2.13
3.33
1.3
1.4
miu/ml
97.1
280.2
—
8
75
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
54
2.86
3.30
1.1
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
60
2.75
3.27
1.6
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
40
224
1.89
3.25
12.6
14.3
inr
1.3
1.2
—
10
37
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
20
85
2.44
3.22
2.1
2.0
iu/l
1.8
5.9
—
6
28
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
8
15
5.44
3.21
1.0
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
55
2.81
3.20
1.5
1.1
u/ml
9.2
1.6
—
9
17
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
79
540
1.61
3.19
1.5
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
20
4.60
3.13
1.0
2.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
74
2.52
3.10
1.2
1.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
8
7.61
3.06
1.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
12
5.93
3.03
1.3
1.1
ug/l
11.2
8.8
—
7
12
(3002256) Pathology report gross observation
58
372
1.68
3.00
1.3
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
5
10.13
2.99
1.2
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
17
4.79
2.93
1.6
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
302
2803
1.98
2.88
5.0
3.9
mmol/l
1.5
1.6
5.12
285
2645
(3008401) Mugwort IgE Ab [Units/volume] in Serum
14
53
2.71
2.83
1.0
1.0
u/ml
0.2
0.8
—
6
20
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
6
8.44
2.76
1.0
2.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
28
147
1.99
2.75
12.1
7.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
14
5.08
2.74
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
21
99
2.20
2.71
1.2
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
10
6.09
2.71
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
10
6.09
2.71
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
10
6.09
2.71
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
17
73
2.40
2.70
1.1
1.4
nmol/l
0.4
0.4
0.10
11
60
(3000330) Specific gravity of Urine by Test strip
22
106
2.15
2.70
2.5
2.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
24
3.82
2.69
1.2
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
15
4.74
2.61
2.4
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
25
3.67
2.59
2.1
3.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
20
4.07
2.58
1.3
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
16
4.45
2.48
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
45
2.73
2.48
1.8
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
47
303
1.64
2.39
2.2
1.8
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
8
6.32
2.38
1.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
8
6.32
2.38
1.8
1.8
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
5
8
6.32
2.38
1.0
2.0
%
75.4
78.4
—
5
8
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
5
8
6.32
2.38
1.0
2.0
mu/l
253.2
621.6
—
5
8
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
17
4.18
2.37
1.1
1.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
17
78
2.24
2.35
1.4
1.2
—
74.3
—
0
7
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
64
447
1.54
2.33
2.1
2.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
242
2161
1.46
2.33
3.9
3.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
28
3.28
2.32
1.4
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
13
4.68
2.28
1.2
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
13
4.68
2.28
1.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
18
3.95
2.26
2.9
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
21
107
2.03
2.26
2.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
29
3.16
2.24
1.6
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
9
5.62
2.22
1.4
2.1
ug/l
42.8
63.3
—
5
9
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
30
3.06
2.16
1.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
14
4.34
2.16
1.2
1.2
iu/ml
187.7
107.2
—
6
14
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
55
2.42
2.15
1.1
1.0
—
—
—
0
0
(3000492) Spirometry study
43
279
1.62
2.14
1.7
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
32
192
1.74
2.12
5.2
3.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
37
2.76
2.12
1.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
31
2.96
2.09
1.0
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
10
5.06
2.08
1.8
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
20
104
1.98
2.05
1.3
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
26
3.13
2.02
1.1
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
17
84
2.08
1.99
2.2
3.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
16
3.80
1.94
1.0
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
16
3.80
1.94
1.0
3.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
16
3.80
1.94
1.0
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
26
151
1.78
1.93
3.8
6.2
mmol/l
5.7
7.8
2.15
26
144
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
58
2.29
1.93
1.3
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
14
65
2.21
1.91
1.6
2.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
82
626
1.41
1.90
3.4
3.0
mg/l
31.2
170.6
0.62
46
370
(3022806) Fractional oxyhemoglobin in Capillary blood
7
22
3.23
1.89
1.7
1.6
%
91.9
90.5
—
7
22
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
17
3.57
1.84
2.0
4.2
u/ml
445.0
748.2
—
6
17
(1002224) Polysomnography panel
25
146
1.77
1.83
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
36
233
1.61
1.83
2.2
3.9
ug/l
2.8
6.8
1.23
27
190
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
12
4.21
1.83
1.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
355
0.56
1.79
1.7
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
66
491
1.43
1.76
2.2
2.1
—
—
—
0
0
(4027681)
6
18
3.37
1.75
1.2
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
36
2.54
1.75
1.7
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
23
133
1.78
1.75
1.9
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
23
133
1.78
1.75
1.9
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
30
2.71
1.73
1.1
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
204
1.63
1.73
1.6
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
23
134
1.77
1.71
1.9
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
36
238
1.58
1.69
2.2
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
69
2.07
1.67
2.0
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
49
2.29
1.65
1.5
1.9
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
14
3.61
1.62
1.2
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
27
168
1.66
1.61
2.3
2.7
mmol/l
1.5
2.2
0.73
21
135
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
49
353
1.46
1.56
1.5
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
21
123
1.76
1.55
2.0
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
10
44
2.31
1.54
3.3
1.8
%
13.6
13.3
—
10
44
(3012544) pH of Venous blood
28
178
1.63
1.54
2.3
2.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
15
3.37
1.53
1.2
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
58
2.11
1.51
1.4
1.1
u/ml
1.6
7.9
—
5
18
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
65
2.04
1.51
1.2
1.1
u/ml
0.4
1.8
—
6
19
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
44
313
1.47
1.49
9.5
5.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
38
2.41
1.46
1.0
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
83
662
1.34
1.46
4.1
3.6
mg/mmol
5.7
9.4
0.50
39
380
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
22
2.76
1.44
2.0
4.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
18
103
1.79
1.44
1.8
2.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
23
2.64
1.37
1.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
257
0.56
1.37
1.3
1.5
—
—
—
0
0
(4024509)
5
17
2.97
1.36
2.6
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
17
2.97
1.36
1.0
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
23
144
1.64
1.36
2.4
2.3
kpa
4.5
4.5
0.09
23
144
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
54
2.07
1.34
1.4
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
279
2635
1.39
1.34
24.2
12.1
%
39.6
39.9
0.39
188
2111
(4306422)
10
48
2.12
1.29
1.2
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
18
2.80
1.29
1.8
1.0
—
—
—
0
0
(4146454)
5
18
2.80
1.29
2.6
3.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
42
307
1.42
1.26
4.1
3.8
%
30.6
32.7
0.62
32
208
(3029634) Reagin Ab [Titer] in Serum by VDRL
8
36
2.25
1.25
2.0
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
25
2.43
1.25
2.0
1.2
pg
33.7
32.4
—
6
25
(3027944) Amphetamines [Presence] in Urine
21
133
1.62
1.20
2.0
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
26
2.33
1.19
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
26
2.33
1.19
1.3
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
20
2.52
1.15
1.2
1.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
40
2.02
1.13
1.1
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
40
2.02
1.13
1.1
1.3
—
—
—
0
0
(3020891) Body temperature
13
73
1.81
1.12
2.2
4.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
21
2.40
1.09
1.0
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
33
2.15
1.06
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
33
2.15
1.06
1.4
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
22
2.29
1.03
2.0
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
47
1.94
1.03
2.9
2.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
47
1.94
1.03
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
47
1.94
1.03
1.3
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
61
1.83
0.99
1.2
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
10
54
1.88
0.97
2.9
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
36
1.96
0.97
1.3
1.5
—
—
—
0
0
(4268621)
7
36
1.96
0.97
3.7
1.8
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
32
0.00
0.95
0.0
15.8
—
875.8
—
0
32
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
32
0.00
0.95
0.0
19.9
—
1750.0
—
0
32
(3036489) Thrombin time
16
101
1.61
0.95
4.3
1.6
s
21.2
20.8
—
10
86
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
28
201
1.43
0.95
1.4
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
37
1.91
0.94
2.4
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
37
1.91
0.94
1.0
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
42
1.93
0.89
2.3
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
42
1.93
0.89
1.1
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
204
0.62
0.89
1.2
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
95
824
1.22
0.84
1.5
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
47
1.72
0.81
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
98
1.56
0.80
1.7
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
11
66
1.69
0.79
3.6
2.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
33
1.83
0.79
1.3
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
97
0.51
0.79
1.6
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
59
1.72
0.76
1.4
1.2
—
—
—
0
0
(44790047)
5
25
2.01
0.73
1.8
1.5
—
—
—
0
0
(44790049)
5
25
2.01
0.73
1.8
1.5
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
5
25
2.01
0.73
1.0
4.0
mu/l
15.8
19.8
—
5
25
(44806118)
5
25
2.01
0.73
1.8
1.5
—
—
—
0
0
(44790048)
5
25
2.01
0.73
1.8
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
104
1164
0.84
0.72
2.9
2.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
26
1.94
0.71
1.2
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
26
1.94
0.71
1.8
2.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
19
260
0.71
0.69
1.9
1.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
27
1.86
0.68
1.0
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
44
1.60
0.65
1.4
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
11
71
1.57
0.63
6.3
3.7
ug/l
1.7
1.5
—
6
55
(3019832) Treponema pallidum Ab [Presence] in Serum
46
382
1.24
0.62
1.4
1.6
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.5
—
1.1
—
0
14
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
52
1.55
0.60
1.1
2.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
91
814
1.16
0.57
1.9
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
66
1.53
0.53
2.1
1.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
134
0.66
0.53
1.2
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
7
47
1.50
0.48
1.3
1.3
mmol/l
6.7
7.5
—
7
31
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
21
168
1.27
0.41
2.3
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
35
1.44
0.39
1.0
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
36
1.39
0.38
1.0
1.2
u/l
10.0
12.4
—
5
30
(3024928) Oxygen saturation in Venous blood
5
37
1.36
0.37
3.0
2.8
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
12
90
1.35
0.36
2.4
2.9
%
52.9
49.5
0.17
12
90
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
43
1.40
0.35
1.3
3.1
u/ml
14.9
50.1
—
6
43
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
43
1.40
0.35
1.0
2.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
44
1.37
0.34
2.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
44
1.37
0.34
2.5
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
44
1.37
0.34
2.5
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
44
1.37
0.34
1.0
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
6
45
1.34
0.34
1.0
4.8
—
3.6
—
0
6
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
46
1.31
0.33
2.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
46
1.31
0.33
2.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
46
1.31
0.33
2.5
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
19
228
0.82
0.30
2.1
2.1
ml/min/173m2
75.0
75.9
—
8
90
(4035726)
27
234
1.17
0.27
1.3
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
127
0.78
0.26
1.1
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
77
1.17
0.24
2.1
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
85
0.70
0.24
1.5
1.6
—
—
—
0
0
(3016750) Collection duration of Urine
0
11
0.00
0.21
0.0
2.2
—
488.0
—
0
5
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
103
0.77
0.21
1.1
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
43
394
1.11
0.21
1.4
1.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
31.9
—
0
13
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
79
1.14
0.15
1.7
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
118
0.84
0.14
1.1
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
118
0.84
0.14
1.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
118
0.84
0.14
1.1
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
118
0.84
0.14
1.1
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
100
0.80
0.14
1.1
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
100
0.80
0.14
1.1
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
48
1.04
0.09
8.4
3.7
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
5
60
0.83
0.08
2.0
2.6
mg/l
1.0
1.4
—
5
55
(3003740) Influenza virus B Ag [Presence] in Specimen
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
127
1.11
0.08
2.1
2.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
11
99
1.11
0.06
2.5
2.1
%
1.7
1.2
0.41
11
99
(40768793) Breast Pathology biopsy report
10
110
0.91
0.05
1.1
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
91
1.10
0.04
1.2
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(4034850)
8
87
0.92
0.00
7.4
9.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
5
56
0.89
0.00
1.2
1.3
ug/l
2.7
3.2
—
5
48
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
76.8
—
0
5
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
8.1
—
0
5
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
6.8
—
25.9
—
0
5
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: DENTAL_TMD_FIBRO – TMD muscular pain linked with fibromyalgia

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).